DLG1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.950600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.108800E-01
Normal-vs-Stage2
9.600800E-01
Normal-vs-Stage3
1.170200E-01
Normal-vs-Stage4
3.737400E-01
Stage1-vs-Stage2
5.729000E-01
Stage1-vs-Stage3
9.101600E-02
Stage1-vs-Stage4
6.013400E-01
Stage2-vs-Stage3
6.579600E-02
Stage2-vs-Stage4
2.354800E-01
Stage3-vs-Stage4
3.935600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.619800E-01
Normal-vs-AfricanAmerican
5.298800E-01
Normal-vs-Asian
8.170600E-01
Caucasian-vs-AfricanAmerican
1.588150E-01
Caucasian-vs-Asian
7.258000E-01
AfricanAmerican-vs-Asian
2.282000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.939400E-01
Normal-vs-Female
9.880400E-01
Male-vs-Female
9.795600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.775200E-01
Normal-vs-Age(41-60Yrs)
5.815400E-01
Normal-vs-Age(61-80Yrs)
8.210200E-01
Normal-vs-Age(81-100Yrs)
5.453600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.407600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.303000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.835400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.536800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.696200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.030000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.056600E-01
Normal-vs-Daily Drinker
3.275200E-01
Normal-vs-Weekly Drinker
6.751200E-01
Normal-vs-Occasional Drinker
5.104400E-01
Normal-vs-Social Drinker
5.331200E-01
Non Drinker-vs-Daily Drinker
2.785600E-01
Non Drinker-vs-Weekly Drinker
9.244000E-01
Non Drinker-vs-Occasional Drinker
1.614000E-02
Non Drinker-vs-Social Drinker
2.904400E-02
Daily Drinker-vs-Weekly Drinker
3.413600E-01
Daily Drinker-vs-Occasional Drinker
4.058300E-03
Daily Drinker-vs-Social Drinker
5.759500E-03
Weekly Drinker-vs-Occasional Drinker
7.277500E-02
Weekly Drinker-vs-Social Drinker
9.098300E-02
Occasional Drinker-vs-Social Drinker
7.715600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.201600E-02
Normal-vs-Grade 2
8.679900E-03
Normal-vs-Grade 3
8.343600E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.062200E-02
Grade 1-vs-Grade 3
1.693740E-02
Grade 1-vs-Grade 4
9.201600E-02
Grade 2-vs-Grade 3
1.912560E-01
Grade 2-vs-Grade 4
8.679900E-03
Grade 3-vs-Grade 4
8.343600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.114200E-01
Normal-vs-NonDiabetic
9.878000E-01
Diabetic-vs-NonDiabetic
6.783700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.404800E-01
Normal-vs-NoPancreatitis
8.559000E-01
Pancreatitis-vs-NoPancreatitis
2.032800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.960800E-01
Normal-vs-N1
9.833400E-01
N0-vs-N1
5.846200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.016200E-01
Normal-vs-TP53-NonMutant
7.345800E-01
TP53-Mutant-vs-TP53-NonMutant
9.578400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
